BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, LEP, T cell differentiation, Obesity, Stem cell, DNA fingerprint, Prozac)
Bookmark Forward

QuickView for FZD3 (gene)


Body Atlas

Most Correlated Tissues

  1. Fetal brain
  2. Prefrontal cortex
  3. Cerebellum
  4. Frontal lobe
  5. Accumbens
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Atherosclerotic occlusive disease
  2. Huntington's disease
  3. Pyloric ulcer
  4. Klinefelter's syndrome, XXY
  5. Helicobacter pylori gastrointestinal tract infection
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. mebhydroline
  2. isonicotinamide
  3. Cefotaxime
  4. 8-(3-Chlorostyryl)-1,3,7-trimethylxanthine
  5. Penicillin G Benzathine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR517A
  2. PTGES
  3. POLR1C
  4. LDB1
  5. RBM15
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 …
  2. Frizzled3 inhibits Vangl2-Prickle3 association to establish planar cell polarity in the vertebrate n…
  3. Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisp…
  4. Feedback regulation of apical progenitor fate by immature neurons through Wnt7-Celsr3-Fzd3 signallin…
  5. The Power of WNT5A and FZD3 Gene Expression and Methylation Status in the Diagnosis-Treatment-Cause …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Tension-Type Headache Gene Expression and Methylation
  2. GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colon…
  3. Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.